Back to search

National and Kapodistrian University of Athens

Κληρονομική σχέση μεταξύ των καρκίνων μαστού, μήτρας και ωοθηκών

Abstract

dc:description

Introduction: Breast cancer is a serious, potentially fatal disease and is the most common malignancy in women. In women it is the second leading cause of death from malignancies. In Greece, every year, about 6,500 women develop cancer. Approximately 70% of breast cancer cases occur in women with no previous family history of the disease and are considered sporadic malignancies. However, in 30% of women breast cancer has a hereditary or familial etiology. Genetic factors, including important related genes (BRCA1, BRCA2, p53, ΡΤΕΝ, CHEK2, ATM, CDH1, MSH2,6, NBS1, RAD50, BRIP1 and PALB2), may be responsible for up to 10% of breast cancer cases in developed countries. A number of studies have revealed that women diagnosed with positive family history present an early age of onset, bilateral breast cancer, advanced stage and negative hormone receptors with a less favorable prognosis. The major characteristic of BRCA1 tumors, in up to 90%, is that they do not express estrogen (ER-) and progesterone (PR-) receptors. Additionally, the majority of these tumors do not express HER2 receptors (HER2-). Neoplasms which are associated with the BRCA2 gene, have a similar expression of hormonal receptors as the sporadic cases. After breast cancer, ovarian cancer is the second cause of death caused by gynecological cancers while endometrial cancer is the fourth most common cancer in women. Inherited endometrial adenocarcinomas appear as synthetic of Lynch or Cowden syndromes. Aim of the study: To establish in Greece, for the first time, a standard survey of patients with a familial history of breast/ovarian/endometrial cancers with the aim of specifically collecting the data (pathological, epidemiological and genetic), from women with familial and hereditary breast/ovarian/endometrial cancers and the ultimate objective of improving genetic counseling. Material and Methods: In collaboration with tree major hospitals in Athens: "Alexandra", "Agios Savvas" and "Metaxa" women aged 19 to 80 years, who were at a high risk of developing hereditary breast/ovarian/endometrial, were studied. We divided our sample into two groups: Familial Breast-Ovarian Cancer (FBOC) group including patients with positive family history (n=361) and Hereditary Breast-Ovarian Cancer (HBOC) group with identified deleterious mutation in one of the most common breast/ovarian susceptibility genes (n=35). After careful analysis of family histories, blood samples of the most phenotypically affected member of the family were taken for genetic testing. Genes (BRCA1, BRCA2, CDH1, MSH2,6, CHEK2) responsible for the development of hereditary breast/ovarian cancer syndrome were tested. Statistical analysis: Methods of descriptive statistics were used to illustrate the results of the analysis with the help of a specific statistical program, SPSS 17.0. P-value of 0.05 and a 95% confidence interval were used as statistical benchmarks. The student’s t test was used for comparison of means between the two groups and the Pearson Chi-Square (Crosstabs) or the Fisher’s exact test when appropriate, for comparisons between proportions. Numerical data were evaluated for normality with the Shapiro-Wilk test. When the criteria for normality were not met a non-parametric test such as Wilcoxon test (Mann-Whitney), Kruskal-Wallis and the X2 test were used. Results: The study lasted three years, from April 2009 to June 2012. From 361 women aged 19 to 80 years with strong history of breast /ovarian cancer (FBOC group), 304 (71.2%) patients, were diagnosed with breast cancer and 31 (7.3%) patients with ovarian cancer. The appearance of both tumors in the same patients was observed in 7 (1.6%) cases, while 10 (2.3%) were diagnosed with endometrial cancer. The mean age of the onset of familial and hereditary breast cancer was 48.15 years (SD=11.17) and 40.36 (SD=8.3) respectively, while the average age of diagnosis of familial and hereditay ovarian was 50.73 (SD=9.8) and 41.33 (SD=8.3) years respectively. The mean age of the onset of familial endometrial cancer was 53.9 years. When evaluating age difference of breast cancer between three generations in each group, the independent t-test indicated the mean age at diagnosis of 55.27 years (SD 14.5) in the older generation (Gen 2) in FBOC group and 50.1 years (SD 13.4) in HBOC group. The difference between Gen 3 and Gen 2 was approximately 7.12 years (P<0.0001) in FBOC group and 9.74 years (P<0.0097) in HBOC group. The most common histological type of breast cancer in both groups was the invasive ductal carcinoma and there was an increased proportion of medullary carcinoma also (14.3% = 4/28). As for ovarian cancer, the epithelial carcinomas were observed in all cases. From the total of 195 cases with known hormone status of familial cancer ER-negative tumors observed in 70 (35.9%) women, while the percentage was much higher in patients with hereditary breast cancer (75%) (P=0.0001). The progesterone receptors were found negative in most hereditary cases (67.9%) (P=0.03). Negative HER-2 overexpression was observed in most breast cancers in both groups with higher prevalence in HBOC group (85.7%) (P=0.03). Interestingly, of all hereditary breast cancers, regardless of the type of mutation, in 57.1% (16/28) of patients found triple negative type of malignancy. Age at first full-term pregnancy was not statistically significantly associated with age of diagnosis of breast cancer in none of the two groups with p-value to be 0.812 and 0.465 for FBOC and HBOC groups accordingly. On the other hand, among parous patients, an increasing number of full-term pregnancies was associated with a statistically significant increase in age of onset of breast cancer (P=0.001) for both groups. Each additional birth increased the age of onset of familial breast cancer by an average of 3.9 years and by 6.7 years for hereditary breast cancer, reducing this way the risk of breast cancer. The younger the age at diagnosis of familial breast cancer the higher was the likelihood of grade 3 tymors, ER and triple negative breast cancer. The same negative correlation for PR and triple negative hormone status with p-value 0.002 and 0.017 respectively existed with hereditary breast cancer. Patients carrying mutations in the BRCA1 gene had greater probability do not express estrogen (P=0.006), progesterone receptors (P=0.03) as well as greater probability of triple negative cancer (P=0.009) compared with patients carrying mutations in the BRCA2 gene. Conclusions: Our study provides information on phenotypic, epidemiological, histological and immunohistochemical characteristics of women with positive family history of breast and ovarian cancer in Greece. Women were diagnosed with HBC in earlier age than those with FBC. Breast and ovarian cancers in both groups appeared to be diagnosed at an earlier age in later generations. Our findings show that FBC tends to present IDC, high grade tumors, ER positive and absence of HER-2 overexpression. Women who carry mutations in the BRCA1 gene had an increased likelihood of IDC, ER/PR- as well as triple negative breast cancer, high grade and consistently poorer prognosis. There is a direct relationship between the age and biomarkers of tumors such as hormone receptors and grade of differentiation. Finally, our data provide evidence that age of first full-term pregnancy did not protect against nether familial nor hereditary breast cancer development. On the other hand, each additional full-term birth increases the age of onset of familial and hereditary breast cancer.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2015

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Triantafyllidou, Olga
  • Τριανταφυλλίδου, Όλγα

Subjects

dc:subject × 11

Rights

dc:rights
Statement dc:rights
  • BY
Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/35994

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Triantafyllidou, Olga; Τριανταφυλλίδου, Όλγα. Κληρονομική σχέση μεταξύ των καρκίνων μαστού, μήτρας και ωοθηκών. National and Kapodistrian University of Athens, 2015. http://hdl.handle.net/10442/hedi/35994